| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |